Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/R9U2 stock hub

FRA/R9U2 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/R9U2is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.5B

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/R9U2FRA/R9U2

—

Loading chart…

In the news

Latest news · FRA/R9U2

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E226.4

P25 n/aP50 n/aP75 n/a

Trailing P/E14.6

P25 n/aP50 n/aP75 n/a

ROE6.6

P25 n/aP50 n/aP75 n/a

ROIC2.7

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/R9U2 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

200

Groups with data

Currency

USD

Showing 200 of 200 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	DE
Employees	5,000
Employees Change	239%
Employees Change Percent	5.24
Enterprise value	EUR 1.7B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	EUR 1.5B
Price	EUR 6.67
Price currency	EUR
Rev Per Employee	207,448.62x
Sic	2834
Symbol	fra/R9U2
Website	https://www.gtigrows.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.83%
EV Earnings	16.46x
EV/EBIT	15.96x
EV/EBITDA	6.13x
EV/FCF	8.81x
EV/Sales	1.67x
FCF yield	12.76%
Forward P/E	226.36x
P/B ratio	0.94x
P/E ratio	14.63x
P/S ratio	1.48x
PE Ratio3 Y	38.43x
PE Ratio5 Y	54.01x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	11.37%
EBITDA Margin	23.78%
FCF margin	18.93%
Gross margin	48.1%
Gross Profit	EUR 498.9M
Gross Profit Growth	-4.04%
Gross Profit Growth Q	0.26%
Gross Profit Growth3 Y	4.39%
Gross Profit Growth5 Y	9.7%
Net Income	EUR 105.2M
Net Income Growth	140.98%
Net Income Growth Q	85.37%
Net Income Growth5 Y	32.61%
Pretax Margin	23.98%
Profit Margin	10.14%
Profit Per Employee	EUR 21,031
ROA	3.15
Roa5y	5.29
ROCE	5.15
ROE	6.63
Roe5y	3.98
ROIC	2.73
Roic5y	3.25

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	29.41%
Cagr3y	-5.9%
Cagr5y	-23.58%
EPS Growth	147.4
EPS Growth Q	89.82
EPS Growth5 Y	30.28
FCF Growth	151.4%
FCF Growth Q	28.31%
FCF Growth5 Y	39.7%
OCF Growth	59.95%
OCF Growth Q	2.13%
OCF Growth3 Y	18.56%
OCF Growth5 Y	22.26%
Revenue Growth	4.83x
Revenue Growth Q	7.39x
Revenue Growth3 Y	5.33x
Revenue Growth5 Y	13.02x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.44
Assets	EUR 2.5B
Cash	EUR 298.8M
Current Assets	EUR 571.4M
Current Liabilities	EUR 164.6M
Debt	EUR 487.7M
Debt EBITDA	EUR 1.67
Debt Equity	EUR 0.3
Debt FCF	EUR 2.48
Equity	EUR 1.6B
Interest Coverage	6.69
Liabilities	EUR 810.5M
Long Term Assets	EUR 1.9B
Long Term Liabilities	EUR 645.9M
Net Cash	EUR -188.9M
Net Cash By Market Cap	EUR -12.28
Net Debt EBITDA	EUR 0.77
Net Debt Equity	EUR 0.11
Net Debt FCF	EUR 0.96
Tangible Book Value	EUR 760.7M
Tangible Book Value Per Share	EUR 3.37

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.47
Inventory Turnover	3.82
Net Working Capital	EUR 154.2M
Quick ratio	2.04
Working Capital	EUR 416M
Working Capital Turnover	EUR 2.81

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.23%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	29.39%
200-day SMA	6.18
3Y total return	-16.68%
50-day SMA	5.81
50-day SMA vs 200-day SMA	50under200
5Y total return	-73.92%
All Time High	33.86
All Time High Change	-80.3%
All Time High Date	2021-02-11
All Time Low	0.02
All Time Low Change	41,587.5%
All Time Low Date	2018-06-18
ATR	0.38
Ch YTD	1.75
High	6.67
High52	8.95
High52 Date	2025-12-15
High52ch	-25.47%
Low	6.67
Low52	4.1
Low52 Date	2025-06-24
Low52ch	62.6%
Ma50ch	14.84%
Price vs 200-day SMA	7.88%
RSI	55.19
RSI Monthly	48.18
RSI Weekly	57.39
Sharpe ratio	0.69x
Sortino ratio	1.24
Total Return	2.23%
Tr YTD	1.75
Tr1m	15%
Tr1w	-0.74%
Tr3m	13.05%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 117.9M
Operating Income Growth	-30.88
Operating Income Growth Q	-4.11
Operating Income Growth3 Y	-12.17
Operating Income Growth5 Y	-1.96
Operating margin	11.37

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	182,004,172%
Net Borrowing	31,238,920.1
Shares Insiders	10.63%
Shares Institutions	4.36%
Shares Qo Q	-1.09%
Shares Yo Y	-2.23%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 157.2M
Average Volume	778.25x
Bv Per Share	7.27
CAPEX	EUR -60.8M
Ch1m	15
Ch1w	-0.74
Ch1y	29.39
Ch3m	13.05
Ch3y	-16.68
Ch5y	-73.92
Ch6m	21.38
Change	-4.03%
Change From Open	0
Close	6.95
Days Gap	-4.03
Depreciation Amortization	125,880,806.9
Earnings Date	2026-05-06
EBIT	EUR 117.9M
EBITDA	EUR 246.7M
EPS	EUR 0.45
F Score	5
FCF	EUR 196.4M
FCF EV Yield	11.35x
Financing CF	-35,109,171
Fiscal Year End	December
Founded	2,014
Goodwill	501,793,385
Graham Number	8.5538
Graham Upside	28.24
Income Tax	EUR 142.3M
Investing CF	-104,418,584
Is Primary Listing	0
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Lynch Fair Value	EUR 11.4
Lynch Upside	70.87
Ma150	6.07
Ma150ch	9.83%
Ma20	6.33
Ma20ch	5.35%
Net CF	117,631,899
Open	6.67
P FCF Ratio	7.83
P OCF Ratio	5.98
Ppne	783,709,375.4
Price Date	2026-05-08
Price EBITDA	EUR 6.24
Ptbv Ratio	2.02
Relative Volume	18.43x
Revenue	1,037,243,099x
SBC By Revenue	3.77x
Share Based Comp	39,150,789
Tax By Revenue	13.72x
Tax Rate	57.21%
Tr6m	21.38%

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/R9U2 pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/R9U2 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/R9U2?

Insider, institutional, and short-interest positioning.

Institutional ownership

+4.4%

Share of float held by funds and institutions

Insider ownership

+10.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-2.2%

Negative means the company is buying back shares.

Technical

FRA/R9U2 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

55.2

Neutral momentum band

Price vs 200-day MA

+7.9%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.69

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/R9U2

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/R9U2 stock rating?

fra/R9U2 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/R9U2 analysis?

The full report lives at /stocks/fra/R9U2/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/R9U2?

The latest report frames fra/R9U2 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/R9U2 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.